Report cover for "PHASE II/III CRO Benchmarking—Small Pharma Market" June, 2021

Phase II/III CRO Benchmarking—Small Pharma Market (2nd Ed.)

$3,450.00 – $6,900.00

Licensing Options

  • SINGLE-USER LICENSE

    A Single-User License allows access to an individual user.

  • SITE-WIDE LICENSE (not available for all reports)

    A Site-Wide License allows access to an organization's employees within a single site/location (e.g. New York City office).

  • ENTERPRISE-WIDE LICENSE

    An Enterprise-Wide License allows access to all employees and sites within an organization.

Related products

  • Select options This product has multiple variants. The options may be chosen on the product page

    Benchmarking Investigator Payments

    $4,900.00 – $9,800.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    Optimizing Feasibility in Clinical Trials

    $2,460.00 – $4,920.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    CRO Selection for Small Pharma and Biotech (2011)

    $2,460.00 – $3,690.00
  • Select options This product has multiple variants. The options may be chosen on the product page

    CRO Quality Benchmarking – Phase I Service Providers (4th Edition)

    $4,900.00 – $9,800.00